Skip to main content
Premium Trial:

Request an Annual Quote

Yamanouchi Subscribes to Celera s Discovery System

NEW YORK, June 25 - Yamanouchi Pharmaceutical, the third largest drug maker in Japan, has signed a five-year subscription to Celera's Discovery System, the company's genomics database and bioinformatics tools.

The agreement allows researchers at Tokyo-based Yamanouchi access to all of Celera's genomics tools through the company's web-based interface. In addition to sequence data, the Discovery System includes software for searching and analyzing Celera's proprietary databases of human and mouse genomic information. 

The companies did not disclose financial details, but in the past, Rockville, Md.-based Celera has charged pharmaceutical companies between $5 million and $15 million a year to use the databases.  

Yamanouchi will apply the information in Celera's databases to its drug discovery efforts in adult and geriatric diseases, the company said. 

The Yamanouchi deal adds to Celera's list of over 30 current subscribers, which include the University of California system, the Max Planck Society for Advancement of Science, the Karolinska Institute, and American Home Products.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.